<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Antiplatelet agents are widely used for the prevention of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, their effects on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation have rarely been evaluated in experimental animals in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>We introduce methods for evaluating antithrombotic action in gerbils and the effects of several antiplatelet agents on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In gerbils 8 to 10 weeks of age, we tightly compressed the unilateral common carotid artery for 2 minutes using the device prepared for this purpose to damage the endothelium </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> formation in the damaged artery was observed directly through the microscope for 30 minutes </plain></SENT>
<SENT sid="5" pm="."><plain>In six animals, the damaged artery was examined immediately after the experiments by electron microscopy </plain></SENT>
<SENT sid="6" pm="."><plain>We studied the effects of antiplatelets by injecting the drugs intravenously 10 minutes before endothelial damage </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In control studies, 70% to 90% of animals developed <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> after arterial compression </plain></SENT>
<SENT sid="8" pm="."><plain>The electron microscopic examination displayed endothelial damage in association with platelet <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> at the damaged site </plain></SENT>
<SENT sid="9" pm="."><plain>Administration of 2 mg/kg aspirin, 3 and 10 mg/kg <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>, and 0.3 and 1.0 mg/kg ibudilast, a novel prostacyclin accelerator, decreased the frequency of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation significantly, whereas 20 mg/kg aspirin and 20 mg/kg <z:chebi fb="0" ids="4653">dipyridamole</z:chebi> failed to decrease <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: This model is considered useful for evaluating the antithrombotic effects of drugs because of its feasibility and high reproducibility </plain></SENT>
<SENT sid="11" pm="."><plain>The present results support the view that a lower dose of aspirin may prevent <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">cerebral vascular accidents</z:e> as efficiently as a higher dose of aspirin </plain></SENT>
</text></document>